Company

Company Compliance & Ethics

Vaccine Business Headquarters of Wantai BioPharm

Xiamen Innovax Biotech Co., Ltd. (“IX”), founded in 2005, is one of China’s leading innovative vaccine companies engaged in the research, development, manufacturing, and commercialization of human vaccines.

As a wholly owned subsidiary of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (Stock Code: 603392.SH) under YST Group, IX serves as the vaccine business headquarters of Wantai BioPharm and is committed to providing high-quality, affordable, and reliable innovative vaccines to populations in need worldwide.

Leveraging its proprietary E. coli-derived virus-like particle (VLP) platform, IX has built a portfolio of innovative vaccines, including the world’s first and only approved Hepatitis E vaccine and the Cecolin portfolio of bivalent and 9-valent HPV vaccines, supporting broader access to cervical cancer prevention and public health worldwide.

20+

Years of Experience

Commercialized Vaccines

200+

R&D personnel

1000+

Employees

History & Milestones

Milestones shaping excellence, driving innovation, and advancing global progress

2000

Joint biopharma lab founded with Xiamen University

2001

YST acquired Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

2005

XM-YST Biotech established for vaccine industrialization

2008

Company merged and renamed Xiamen INNOVAX Biotech

2011

Hecolin approved in China, as the world’s first and only Hepatitis E vaccine

2019

Cecolin, the first domestic cervical cancer vaccine, was approved in China

2021

Cecolin received WHO PQ and entered global markets

2023

Hecolin included in WHO ICG HEV vaccine stockpile

2025

Cecolin 9, the world’s second 9-valent HPV vaccine, approved in China

R&D and Manufacturing Network

Scaled Facilities for Research, Manufacturing, and Reliable Supply

Headquarters & Diagnostics Campus

Beijing

36,000m²

R&D and Innovation Center

Beijing

60,000m²

Vaccine Business Headquarters

Xiamen

93,000m²

HEV Manufacturing Site

Xiamen

13,000m²

Diagnostics Manufacturing Campus

Xiamen

190,000m²

Culture & Values

Mission

We are committed to providing high-quality and affordable vaccines to enhance human well-being.

Vision

To pioneer the future of vaccines.

Values

User Orientation
Innovation and Excellence
Diligent Action and Accountability
Inclusion and Collaboration

Management Philosophy

Quality-Driven
Market-Oriented
People-Centric
Agile&Efficient

Global Partnerships

IX works with global partners across science, industry, and public health to advance vaccine access.

Qualification and Honor

Recognized excellence through qualifications and honors, reflecting trust and credibility.

2012 WIPO SIPO AWARD FOR CHINESE OUTSTANDING PATENTED INVENTION

Our Group

Prominent Chinese investment enterprises shaping the future of key industries.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.（SSE603392）

Founded in 1991, is a leading high-tech enterprise specializing in the research, development, and production of biological diagnostic tests and vaccines.

Nongfu Spring Co., Ltd.(HKEX 09633）

Founded in 1996, Nongfu Spring is a leading Chinese beverage company specializing in bottled water and ready-to-drink beverages.

Yangshengtang Co., Ltd.

Founded in 1993, Yangshengtang is a leading pharmaceutical company in China.

Cecolin 9 for Public Cecolin 9 for HCPs Vaccine Portfolio Contact Us Media Report an Adverse Event

Company

Vaccine Business Headquarters of Wantai BioPharm

History & Milestones

R&D and Manufacturing Network

Headquarters & Diagnostics Campus

R&D and Innovation Center

Vaccine Business Headquarters

HEV Manufacturing Site

Diagnostics Manufacturing Campus

Culture & Values

Mission

Vision

Values

Management Philosophy

Global Partnerships

Qualification and Honor

2012 WIPO SIPO AWARD FOR CHINESE OUTSTANDING PATENTED INVENTION

2025 WIPO CNIPA AWARD FOR CHINESE OUTSTANDING PATENTED INVENTION

AEO CERTIFICATE

High Tech Enterprise Certificate

National Green Factory

Top 100 ESG Reporting Companies in China (2025)

National Intellectual Property Advantage Enterprise

Most Innovative Asian Biotech Excellence Award

Our Group

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.（SSE603392）

Nongfu Spring Co., Ltd.(HKEX 09633）

Yangshengtang Co., Ltd.

Company

Vaccine Business Headquarters of Wantai BioPharm

History & Milestones

R&D and Manufacturing Network

Headquarters & Diagnostics Campus

R&D and Innovation Center

Vaccine Business Headquarters

HEV Manufacturing Site

Diagnostics Manufacturing Campus

Culture & Values

Mission

Vision

Values

Management Philosophy

Global Partnerships

Qualification and Honor

2012 WIPO SIPO AWARD FOR CHINESE OUTSTANDING PATENTED INVENTION

2025 WIPO CNIPA AWARD FOR CHINESE OUTSTANDING PATENTED INVENTION

AEO CERTIFICATE

High Tech Enterprise Certificate

National Green Factory

Top 100 ESG Reporting Companies in China (2025)

National Intellectual Property Advantage Enterprise

Most Innovative Asian Biotech Excellence Award

Our Group

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.（SSE603392）

Nongfu Spring Co., Ltd.(HKEX 09633）

Yangshengtang Co., Ltd.

Change location

Welcome to the Cecolin 9 Information Website

www.xiameninnovax.com says